Rising prices, especially for prescription drugs, surgery, and emergency department visits, caused overall healthcare spending in 2016 to grow faster than at any time in the last 5 years; however, Americans used the same amount or less healthcare in 2016 compared with 2015, according to a report by the Health Care Cost Institute.
Rising prices, especially for prescription drugs, surgery, and emergency department (ED) visits, caused overall healthcare spending in 2016 to grow faster than at any time in the last 5 years, according to the Health Care Cost Institute (HCCI). However, Americans used the same amount or less healthcare in 2016 compared with 2015, according to the HCCI’s annual Health Care Cost and Utilization Report, which analyzed healthcare spending and utilization from 2012 to 2016 for people up to age 65 with employer-sponsored health insurance.
Four major health insurers contributed data to HCCI for the purposes of producing a national, multi-payer, commercial healthcare claims database: Aetna, Humana, Kaiser Permanente, and UnitedHealthcare.
“It is time to have a national conversation on the role of price increases in the growth of healthcare spending,” Niall Brennan, MPP, president of HCCI, said in a statement. “Despite the progress made in recent years on value-based care, the reality is that working Americans are using less care but paying more for it every year. Rising prices, especially for prescription drugs, surgery, and emergency department visits, have been primary drivers of faster growth in recent years.
Prescription drug spending had cumulative growth of 27%, despite a flat or decreasing trend in generic drug prices and despite a fall in utilization of brand prescription drugs. During the study period, the price of brand prescription drugs soared by double digits, which drove drug spending higher.
Three classes of drugs were behind the rise in prescription drug spending, the report found:
While the number of ED visits rose just slightly, the average price per visit grew steadily over the 5-year study for a 31.5% cumulative increase, driving the increase in outpatient spending.
The average price of surgery rose as well, pushing up spending for both inpatient and outpatient care. The average price for surgical admissions increased by nearly $10,000 or 30%, despite a -16% cumulative decline in utilization. The price for outpatient surgery rose more than 19%.
The study also reported:
“While consumers, especially those with employer-sponsored insurance, may not feel the direct impact of these charges via OOP payments, they ultimately pay through increased premiums and decreased benefits,” said Brennan.
HCCI is an independent, nonpartisan research organization that analyzes the causes of the rise in health spending.
Real-World Study Reveals Key Insights into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Gene, Light Therapy Combo Shows Promise Against Prostate Cancer Cells in Proof-of-Concept Study
April 18th 2024In their preclinical model, the researchers found efficacy both in vitro and in vivo by using CRISPR-Cas9 to mimic porphyria and combining the technology with light therapy.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Collecting SDOH Data Can Assess Risk of Medical Nonadherence, Improve HEI and Star Ratings
April 18th 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, a panel of presenters explored changes coming to Medicare that incorporate social determinants of health (SDOH) data to improve patient and health system outcomes.
Read More